Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Methodological standard · §5

CEI-MS-19 — system suitability and acceptance criteria

The performance the system must demonstrate, and the criteria a result must meet to be reportable.

Document identifier
CEI-MS-19/5
Series
Methodological standard
Version
1.0
Published
20 Mar 2025
Last reviewed
20 Dec 2025
Next review
20 Dec 2028
Identifier
10.71829/cei.meth.16
Certainty
High
Cycle
2025 Q1
Category
Chromatographic purity

§5System suitability and acceptance criteria

§5.1System suitability

Table 1. System suitability criteria. A determination is reportable only where every criterion is met at the time of analysis.

ParameterCriterionWhat it establishes
Retention factor of the main peak2–10Adequate interaction with the stationary phase
Resolution, main peak to injection disturbance≥ 3.0Freedom from void interference
Resolution, main peak to nearest generated degradant≥ 1.5Specificity
Repeatability of retention timeRelative standard deviation ≤ 1.0 %Method stability

§5.2Acceptance criteria

  • A purity determination for a poorly retained analyte is reportable only under this standard, with the mechanism and retention factor stated.
  • A purity figure for such a compound obtained under CEI-MS-01 conditions is recorded by the Institute as analytically unsupportable, and the Institute notes that such figures are nonetheless in general circulation for several compounds in its monograph series.

§5.3Limitations

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. European Directorate for the Quality of Medicines & HealthCare. General Chapter 2.2.29 Liquid Chromatography. European Pharmacopoeia 2023;11th edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.